Investment
Features
FeesSafety
Academy
More
Pluang+

Grove Bank & Trust boosts stake in Vertex Pharmaceuticals by 375% in Q4, signaling strong investor interest.

Market News
22 Mar 2026
Defense World
View Source
Bullish
pluang ai news

Grove Bank & Trust increased its holdings in Vertex Pharmaceuticals by 374.7% in the fourth quarter, purchasing an additional 1,645 shares worth $945,000. This move reflects growing institutional confidence, as 90.96% of Vertex's stock is owned by institutional investors and hedge funds. Despite some insider selling, multiple analysts have upgraded Vertex's stock with price targets rising up to $585, maintaining a consensus 'Moderate Buy' rating. Vertex reported solid quarterly earnings with revenue growth and expects strong earnings per share for the fiscal year, supporting positive market sentiment.

More News (VRTX)

banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App